162 related articles for article (PubMed ID: 33099213)
1. The HOXB13 p.Gly84Glu variant observed in an extended five generation high-risk prostate cancer pedigree supports risk association for multiple cancer sites.
Cannon-Albright LA; Stevens J; Teerlink CC; Agarwal N
Cancer Epidemiol; 2020 Dec; 69():101834. PubMed ID: 33099213
[TBL] [Abstract][Full Text] [Related]
2. Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.
Akbari MR; Anderson LN; Buchanan DD; Clendenning M; Jenkins MA; Win AK; Hopper JL; Giles GG; Nam R; Narod S; Gallinger S; Cleary SP
Cancer Epidemiol; 2013 Aug; 37(4):424-7. PubMed ID: 23541221
[TBL] [Abstract][Full Text] [Related]
3. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.
Beebe-Dimmer JL; Hathcock M; Yee C; Okoth LA; Ewing CM; Isaacs WB; Cooney KA; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1366-72. PubMed ID: 26108461
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
5. A Rare Variant in
Cannon-Albright LA; Teerlink CC; Stevens J; Huang FW; Sipeky C; Schleutker J; Hernandez R; Facelli J; Agarwal N; Trump DL
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34063511
[TBL] [Abstract][Full Text] [Related]
6. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
[TBL] [Abstract][Full Text] [Related]
7. Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates.
Cai Q; Wang X; Li X; Gong R; Guo X; Tang Y; Yang K; Niu Y; Zhao Y
Oncotarget; 2015 Dec; 6(39):42312-21. PubMed ID: 26517352
[TBL] [Abstract][Full Text] [Related]
8. The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.
Akbari MR; Kluźniak W; Rodin R; Li S; Wokołorczyk D; Royer R; Kashyap A; Menkiszak J; Lubinski J; Narod SA; Cybulski C
Breast Cancer Res Treat; 2012 Dec; 136(3):907-9. PubMed ID: 23099437
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.
Breyer JP; Avritt TG; McReynolds KM; Dupont WD; Smith JR
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738
[TBL] [Abstract][Full Text] [Related]
10. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
Darst BF; Hughley R; Pfennig A; Hazra U; Fan C; Wan P; Sheng X; Xia L; Andrews C; Chen F; Berndt SI; Kote-Jarai Z; Govindasami K; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Huff CD; Strom SS; Isaacs WB; Park JY; Zheng W; Ostrander EA; Walsh PC; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Stanford JL; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach RJ; Gundell SM; Pooler L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Brureau L; Blot WJ; Biritwum R; Tay E; Truelove A; Niwa S; Tettey Y; Varma R; McKean-Cowdin R; Torres M; Jalloh M; Magueye Gueye S; Niang L; Ogunbiyi O; Oladimeji Idowu M; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Yeboah ED; Mensah JE; Anthony Adjei A; Diop H; Cook MB; Chanock SJ; Watya S; Eeles RA; Chiang CWK; Lachance J; Rebbeck TR; Conti DV; Haiman CA
Eur Urol; 2022 May; 81(5):458-462. PubMed ID: 35031163
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.
Beebe-Dimmer JL; Isaacs WB; Zuhlke KA; Yee C; Walsh PC; Isaacs SD; Johnson AM; Ewing CE; Humphreys EB; Chowdhury WH; Montie JE; Cooney KA
BJU Int; 2014 May; 113(5):830-5. PubMed ID: 24148311
[TBL] [Abstract][Full Text] [Related]
12. Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
Marlin R; Créoff M; Merle S; Jean-Marie-Flore M; Rose M; Malsa S; Promeyrat X; Martin F; Comlan G; Rabia N; Taouil T; Issoufaly I; Escarmant P; Vinh-Hung V; Béra O
Prostate; 2020 May; 80(6):463-470. PubMed ID: 32040869
[TBL] [Abstract][Full Text] [Related]
13. Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.
FitzGerald LM; Raspin K; Marthick JR; Field MA; Malley RC; Thomson RJ; Blackburn NB; Banks A; Charlesworth JC; Donovan S; Dickinson JL
Sci Rep; 2017 Dec; 7(1):17778. PubMed ID: 29259341
[TBL] [Abstract][Full Text] [Related]
14. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.
Maia S; Cardoso M; Pinto P; Pinheiro M; Santos C; Peixoto A; Bento MJ; Oliveira J; Henrique R; Jerónimo C; Teixeira MR
PLoS One; 2015; 10(7):e0132728. PubMed ID: 26176944
[TBL] [Abstract][Full Text] [Related]
15. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
16. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in HOXB13 and prostate-cancer risk.
Ewing CM; Ray AM; Lange EM; Zuhlke KA; Robbins CM; Tembe WD; Wiley KE; Isaacs SD; Johng D; Wang Y; Bizon C; Yan G; Gielzak M; Partin AW; Shanmugam V; Izatt T; Sinari S; Craig DW; Zheng SL; Walsh PC; Montie JE; Xu J; Carpten JD; Isaacs WB; Cooney KA
N Engl J Med; 2012 Jan; 366(2):141-9. PubMed ID: 22236224
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Interaction of
Sipeky C; Gao P; Zhang Q; Wang L; Ettala O; Talala KM; Tammela TLJ; Auvinen A; Wiklund F; Wei GH; Schleutker J
Clin Cancer Res; 2018 Dec; 24(24):6265-6276. PubMed ID: 30181389
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.
Handorf E; Crumpler N; Gross L; Giri VN
J Genet Couns; 2014 Jun; 23(3):371-6. PubMed ID: 24310616
[TBL] [Abstract][Full Text] [Related]
20. Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E.
MacInnis RJ; Severi G; Baglietto L; Dowty JG; Jenkins MA; Southey MC; Hopper JL; Giles GG
PLoS One; 2013; 8(2):e54727. PubMed ID: 23457453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
